Jennifer Chao
Director/Board Member at ENDO INTERNATIONAL PLC
Net worth: 15 $ as of 2024-04-29
Profile
Jennifer M.
Chao is the founder and the Managing Partner of Corestrategies Management LLC, which was founded in 2008.
She is currently serving as an Independent Director at Endo International Plc and Cardiol Therapeutics, Inc. She is also a Director at Endo Pharmaceuticals, Inc. Ms. Chao previously served as the Chairman of BioSpecifics Technologies Corp.
from 2019 to 2020.
She has also held positions as a Managing Director at RBC Capital Markets, Inc., an Independent Director at Edesa Biotech, Inc. from 2022 to 2023, a Research Analyst at Deutsche Bank Securities, Inc., and a Vice President at Leerink Swann & Co. Ms. Chao obtained her undergraduate degree from New York University in 1992.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ENDO INTERNATIONAL PLC
0.01% | 2023-04-11 | 24,921 ( 0.01% ) | 15 $ | 2024-04-29 |
| 2024-02-28 | 0 ( -.--% ) | - $ | 2024-04-29 |
Jennifer Chao active positions
| Companies | Position | Start |
|---|---|---|
| ENDO INTERNATIONAL PLC | Director/Board Member | 2021-02-16 |
| CARDIOL THERAPEUTICS INC. | Director/Board Member | 2022-03-14 |
| Corestrategies Management LLC | Founder | 2007-12-31 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Director/Board Member | - |
Former positions of Jennifer Chao
| Companies | Position | End |
|---|---|---|
| EDESA BIOTECH, INC. | Director/Board Member | 2023-05-31 |
| BIOSPECIFICS TECHNOLOGIES CORP. | Chairman | 2020-12-01 |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Analyst-Equity | 2008-02-28 |
| Leerink Swann & Co. | Corporate Officer/Principal | - |
RBC Capital Markets, Inc.
 RBC Capital Markets, Inc. Investment ManagersFinance Part of Royal Bank of Canada, RBC Capital Markets, Inc. provides investment advice. The private company is based in Albany, NY. | Corporate Officer/Principal | - |
Training of Jennifer Chao
| New York University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CARDIOL THERAPEUTICS INC. | Health Technology |
| EDESA BIOTECH, INC. | Health Technology |
| Private companies | 7 |
|---|---|
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Finance |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Part of Royal Bank of Canada, RBC Capital Markets, Inc. provides investment advice. The private company is based in Albany, NY. | Finance |
| Leerink Swann & Co. | Finance |
| Corestrategies Management LLC |
- Stock Market
- Insiders
- Jennifer Chao
